Related Experiment Video
Updated: May 28, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
Epidemiology and diagnosis of multiple sclerosis
Ghaniah Hassan-Smith1, Michael R Douglas
1Centre for Traditional Inflammation Research, University of Birmingham Research Laboratories, Queen Elizabeth Hospital, Birmingham. ghaniah_1@hotmail.com
Insights
Multiple sclerosis (MS) is an inflammatory central nervous system (CNS) disease affecting young adults. This condition has significant long-term personal, professional, and economic impacts, costing the UK economy billions.
Area of Science:
- Neurology
- Immunology
- Public Health
Background:
- Multiple sclerosis (MS) is a chronic inflammatory disease targeting the central nervous system (CNS).
- MS predominantly affects young adults, leading to lifelong personal and professional challenges.
- The economic burden of MS is substantial due to its impact on the working-age population.
Purpose of the Study:
- To highlight the significant economic impact of multiple sclerosis on the UK economy.
- To underscore the long-term implications of MS for patients of working age.
Main Methods:
- Literature review and economic analysis based on existing data.
- Synthesis of information regarding the prevalence and cost of MS in the UK.
Main Results:
- The economic cost of MS to the UK economy was estimated at approximately £1.4 billion (McCrone et al, 2008).
- The majority of individuals diagnosed with MS are of working age, contributing to the significant economic impact.
Conclusions:
- Multiple sclerosis imposes a considerable economic burden on national economies.
- Early diagnosis and management strategies are crucial to mitigate the long-term personal and economic consequences of MS.
Abstract:
Multiple sclerosis is an inflammatory disease of the CNS. The disease is predominantly diagnosed in young adults, with long-term implications for both their personal and professional lives. The economic impact of the condition is particularly significant as the majority of patients are of working age, costing the UK economy approximately £1.4 billion (McCrone et al, 2008).
Related Concept Videos
Multiple Sclerosis l: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Diagnostic and Statistical Manual of Mental Disorders (DSM)
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Investigation of Disease Outbreaks

